Financials
| Div Yield |
7.0% |
12.6% |
| Div Cover |
2.28 |
n/a |
| Op Mrgn |
42.0% |
n/a |
| ROCE |
176.3% |
|
| P/E |
73.03 |
16.07 |
| PEG |
(0.08) |
2.80 |
| Pr/Revenue |
23.10 |
n/a |
| Pr/Book |
2.83 |
|
| Revenue |
34.7% |
n/a |
| PBT |
59.9% |
n/a |
| EPS |
38.5% |
498.3% |
| DPS |
47.2% |
|
| 1 week |
5,744.30 |
-14.00 |
-0.24% |
| 1 month |
5,372.91 |
+357.39 |
+6.65% |
| 3 months |
5,525.37 |
+204.93 |
+3.71% |
| 6 months |
5,150.08 |
+580.22 |
+11.27% |
| 1 year |
4,520.89 |
+1,209.41 |
+26.75% |
| VTY | 20-Apr-26 |
Buy |
Rob Woodward |
353.00p | 18,319 |
£64,666.07 |
| MTLN | 20-Apr-26 |
Buy |
Evangelos Mytilineos |
34.48 | 30,000 |
1,034,352.04 |
| CGT | 17-Apr-26 |
Buy |
Karl Sternberg |
5,095.00p | 982 |
£50,032.90 |
| RPI |
577.50p |
-5.1% |
| RR. |
1,202.20p |
-4.8% |
| GEN |
297.00p |
-3.2% |
| BCG |
200.60p |
-2.9% |
| BA. |
2,177.50p |
-2.8% |
| PAF |
157.90p |
-2.7% |
| MRO |
541.80p |
-2.6% |
| ABF |
1,840.50p |
-2.4% |
| GSK |
2,094.00p |
-2.3% |
| HAS |
33.54p |
-2.2% |
Top of Page
You are here:
research